Amorphical is a pioneering biotech company engaged in the development of revolutionary dietary supplements and drugs for the treatment and prevention of human metabolic bone disease. In preparation for a round of financing, we hired BioMarketing to assist us in generating a business plan for investors. We had a clear vision in mind of what the document should look like, but we needed someone that will break it down and fit all the parts together. BioMarketing worked closely with us and helped put it all together. They were very pleasant to work with and accommodated my tight deadlines. The end result is exactly what I aimed for: a professional business plan that stands out, and that I feel confident presenting to investors.

- Dr. Assaf Shechter, CEO